Valiant Pre/Post
- Manufacturer
- ABS Global Inc.
- Effective date
- 2023-08-03
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 02:42:11
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SAFE HANDLING WARNING SECTION
KEEP OUT OF REACH OF CHILDREN
NOT FOR HUMAN USE
Warning
Causes eye irritation.
Wash skin thoroughly after handling.
Do not mix with bleach or other chlorinated products – will cause chlorine gas.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/ attention.
VETERINARY INDICATIONS SECTION
DIRECTIONS FOR USE
Mix Directions: Add 3.5 ounces of Valiant Catalyst (US) to one gallon of Valiant Pre/Post (US) or mix (27.3 mL Valiant Catalyst (US) to 1 liter Valiant Pre/Post (US)) and mix. Inverting the container approximately 5-7 times will adequately mix the two solutions. This mixed solution will remain stable for 7 days. After 7 days, discard solution and mix a new solution.
IMPORTANT: Do not add mixed Valiant Pre/Post (US) ready-to-use to any other teat dip or other products. If transferred from this container to any other, make sure the other container is thoroughly pre-cleaned and bears the proper container labeling for Valiant Pre/Post (US). Use of a complete cow-care program including both pre and post dipping may aid in reducing the spread of organisms which may cause mastitis.
DIRECTIONS FOR TEAT DIPPING
Pre-Milking: Fill teat dip cup with Valiant Pre/Post (US). Before each cow is milked, dip the teats as far as possible into the teat dip cup containing Valiant Pre/Post (US). Wipe teats dry after dipping, using single-service towels to avoid contamination of milk. Udder and teats which are heavily soiled should be washed before using a pre-milking teat dip. Teats should be dried with a single-service towel and dipped in Valiant Pre/Post (US), wiping teats dry before milking.
Post-Milking: Immediately after milking, use Valiant Pre/Post (US) at full strength. Submerge teats 2/3 their length in Valiant Pre/Post (US). If product in dip cup becomes visibly dirty, discard contents and replenish with product. Do not reuse or return unused product to the original container.
Do not turn cows into freezing weather until Valiant Pre/Post (US) is completely dry.
NOTE: Valiant Pre/Post (US) is not intended to cure or help in the healing of chapped or irritated teats. In case of irritation or chapping, have the condition examined and, if necessary, treated by a veterinarian.
OTHER SAFETY INFORMATION
READ SAFETY DATA SHEET (SDS) BEFORE USING THIS PRODUCT
EMERGENCY HEALTH INFORMATION: 1 800 328 0026. If located outside the United States and Canada, call collect 1 651 222 5352 (number is in the US).
Principal display panel and representative container
Valiant
Quality milk system
ABS
Pre/Post (US)
Sanitizing Pre/Post Teat Dip
Base – For use exclusively with Valiant Catalyst (US)
An aid in reducing the spread of organisms which may cause mastitis.
ACTIVE INGREDIENTS:
Lactic Acid.........................................................................................................2.3%
Linear Dodecyl Benzene Sulfonic Acid................................................................1.6%
INERT INGREDIENTS:................................................................................ 96.1%
(contains lanolin and propylene glycol)
TOTAL:.........................................................................................................100.0%
6300466
18.9 L (5 US GAL)
Distributed by:
ABS Global, Inc. · P.O. Box 459
DeForest, Wisconsin USA 53532
Manufactured by:
Ecolab Inc. ∙ 1 Ecolab Place ∙
St. Paul MN 55102 USA ·
tel: 1 800 392 3392
© 2018 Ecolab USA Inc · All rights reserved
Made in U.S.A.
703828/5301/1118
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LACTIC ACID, UNSPECIFIED FORM Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20220121 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59282-102-16 | Valiant Pre/Post | 18900 mL in 1 PAIL | SOLUTION | 18900 | 5 | |
| 59282-102-17 | Valiant Pre/Post | 56780 mL in 1 DRUM | SOLUTION | 56780 | 5 | |
| 59282-102-21 | Valiant Pre/Post | 208200 mL in 1 DRUM | SOLUTION | 208200 | 5 | |
| 59282-102-44 | Valiant Pre/Post | 1150000 mL in 1 PACKAGE | SOLUTION | 1150000 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| DODECYLBENZENESULFONIC ACID | ACTIVE INGREDIENT | 60NSK897G9 | 2 | |
| LACTIC ACID | ACTIVE INGREDIENT | 33X04XA5AT | 2 | |
| DODECYLBENZENESULFONIC ACID | ACTIVE MOIETY | 60NSK897G9 | 2 | |
| LACTIC ACID | ACTIVE MOIETY | 33X04XA5AT | 2 | |
| PEG-75 LANOLIN | INACTIVE INGREDIENT | 09179OX7TB | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- Valiant Pre/Post
- Lactic Acid and Dodecylbenzene Sulfonic Acid
- LACTIC ACID
- DODECYLBENZENESULFONIC ACID
- PROPYLENE GLYCOL
- PEG-75 LANOLIN
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 59282-102 | 59282-102-16, 59282-102-17, 59282-102-21, 59282-102-44 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTIC ACID | 33X04XA5AT | ACTIB |
| DODECYLBENZENESULFONIC ACID | 60NSK897G9 | ACTIB |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PEG-75 LANOLIN | 09179OX7TB | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | EMULSION / TOPICAL | 1.5 %w/w | ||
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | SOLUTION / TOPICAL | 1 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / RESPIRATORY (INHALATION) | 25 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION / TOPICAL | 3392 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / OPHTHALMIC | 0.6 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / TOPICAL | 1800 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / TOPICAL | 0.75 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | JELLY / TOPICAL | 20 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, EXTENDED RELEASE / ORAL | 9 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | 5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SWAB / TOPICAL | 34.6 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / ORAL | 22602 mg | ||
| PEG-75 LANOLIN | PEG-75 LANOLIN | 09179OX7TB | AEROSOL / TOPICAL | 1.5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, METERED / RECTAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM, AUGMENTED / TOPICAL | 8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | PASTE / DENTAL | 0.5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / INTRAVENOUS | 50.33 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TAMPON / VAGINAL | 62.1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, SOLUBLE / BUCCAL | 5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYSTEM / TOPICAL | 4200 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / TOPICAL | 5.28 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / VAGINAL | 1225 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | 4000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / SUBCUTANEOUS | 1.4 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | 9306 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / OPHTHALMIC | 0.44 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | 7459 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / VAGINAL | 6.4 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / OPHTHALMIC | 1 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / INTRAVENOUS | 5 %w/v |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
